Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angioplasty equals bypass surgery outcomes in limb ischaemic trial:

This article was originally published in Clinica

Executive Summary

Angioplasty when used as a treatment for severe limb ischaemia yields similar outcomes to bypass surgery, according to what is claimed to be the first study to formally validate the percutaneous approach as an acceptable option for patients with the disease. The 452-patient, multicentre UK trial, called BASIL, found that after six months, the strategies did not differ in amputation-free survival outcomes. In the short-term, angioplasty was associated with less illness, lower cost and shorter hospital stays, compared with surgery. However, the technique had a higher failure and re-intervention rate than surgery. The findings appear in The Lancet (December 3).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058090

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel